|
|
immune effector process
|
GO:0002252 |
321 |
0.481
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.451
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.374
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.362
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.358
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.327
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.275
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.263
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.261
|
|
|
|
metanephric glomerular visceral epithelial cell development
|
GO:0072249 |
2 |
0.256
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.246
|
|
|
|
regulation of t helper 1 cell cytokine production
|
GO:2000554 |
1 |
0.242
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.233
|
Fly |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.223
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.210
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.205
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.195
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.173
|
|
|
|
regulation of type iia hypersensitivity
|
GO:0001796 |
4 |
0.166
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.162
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.162
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.159
|
|
|
|
metanephric glomerular visceral epithelial cell differentiation
|
GO:0072248 |
2 |
0.156
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.155
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.154
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.151
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.150
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.145
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.141
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.141
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.131
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.130
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.128
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.128
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.126
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.126
|
Fly |
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.123
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.121
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.120
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.117
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.111
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.111
|
|
|
|
positive regulation of b cell mediated immunity
|
GO:0002714 |
26 |
0.110
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.106
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.106
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.105
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.105
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.104
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.104
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.103
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.103
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.098
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.096
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.096
|
Fly |
|
|
regulation of b cell chemotaxis
|
GO:2000537 |
2 |
0.096
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.095
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.094
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.094
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.094
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.093
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.093
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.093
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.091
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.090
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.087
|
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.085
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.084
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.083
|
|
|
|
detection of oxidative stress
|
GO:0070994 |
1 |
0.083
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.082
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.081
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.081
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.081
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.080
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.080
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.080
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.077
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.077
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.077
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.077
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.076
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.076
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.075
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.074
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.074
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.073
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.073
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.073
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.072
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.072
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.071
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.071
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.071
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.070
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.070
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.070
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.069
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.069
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.069
|
|
|
|
antigen processing and presentation of peptide antigen via mhc class ii
|
GO:0002495 |
17 |
0.069
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.068
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.068
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.068
|
|
|
|
regulation of inflammatory response to antigenic stimulus
|
GO:0002861 |
21 |
0.067
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.067
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.066
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.066
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.066
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.066
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.066
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.066
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.065
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.065
|
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.064
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.064
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.063
|
Mouse |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.063
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.063
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.063
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.062
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.062
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.061
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.061
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.061
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.060
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.060
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.060
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.059
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.059
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.059
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.059
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.059
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.059
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.058
|
|
|
|
adiponectin secretion
|
GO:0070162 |
2 |
0.058
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.057
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.057
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.057
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.057
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.057
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.056
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.056
|
|
|
|
metanephric glomerular epithelial cell differentiation
|
GO:0072312 |
2 |
0.055
|
|
|
|
positive regulation of type iii hypersensitivity
|
GO:0001805 |
3 |
0.055
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.054
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.054
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.054
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.053
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.053
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.052
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.052
|
|
|
|
negative regulation of hypersensitivity
|
GO:0002884 |
3 |
0.052
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.051
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.051
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.051
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.051
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.051
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.051
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.051
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.049
|
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.049
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.049
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.049
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.049
|
|
|
|
positive regulation of immunoglobulin mediated immune response
|
GO:0002891 |
26 |
0.048
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.048
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.048
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.048
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.048
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.047
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.047
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.047
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.047
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.047
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.046
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.046
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.046
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.046
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.045
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.045
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.045
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.045
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.045
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.044
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.044
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.044
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.044
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.043
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.043
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.043
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.043
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.043
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.042
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.042
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.042
|
|
|
|
granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0042253 |
2 |
0.041
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.041
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.041
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.041
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.040
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.040
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.040
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.040
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.040
|
|
|
|
negative regulation of macrophage apoptotic process
|
GO:2000110 |
3 |
0.039
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.039
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.039
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.039
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.039
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.039
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.039
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.038
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.038
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.038
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.038
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.038
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.038
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.037
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.037
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.037
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.037
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.036
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.036
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.036
|
|
|
|
regulation of type iii hypersensitivity
|
GO:0001803 |
3 |
0.036
|
|
|
|
hypersensitivity
|
GO:0002524 |
10 |
0.036
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.036
|
|
|
|
cellular response to interleukin 4
|
GO:0071353 |
21 |
0.036
|
|
|
|
regulation of adiponectin secretion
|
GO:0070163 |
2 |
0.035
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.035
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.035
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.035
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.035
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.035
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.034
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.034
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.034
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.034
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.034
|
|
|
|
antigen processing and presentation of exogenous peptide antigen
|
GO:0002478 |
21 |
0.034
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.034
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.034
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.033
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.033
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.033
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.033
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.033
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.033
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.033
|
|
|
|
cell migration involved in metanephros development
|
GO:0035788 |
2 |
0.033
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.032
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.032
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.032
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.032
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.032
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.032
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.032
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.032
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.032
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.032
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.031
|
|
|
|
fc epsilon receptor signaling pathway
|
GO:0038095 |
3 |
0.031
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.031
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.031
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.031
|
|
|
|
positive regulation of mitochondrial calcium ion concentration
|
GO:0051561 |
3 |
0.031
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.031
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.030
|
|
|
|
positive regulation of cd4 positive alpha beta t cell proliferation
|
GO:2000563 |
1 |
0.030
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.030
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.030
|
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
14 |
0.030
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.030
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.030
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.030
|
|
|
|
regulation of antigen processing and presentation
|
GO:0002577 |
10 |
0.030
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.029
|
|
|
|
natural killer cell chemotaxis
|
GO:0035747 |
1 |
0.029
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.029
|
|
|
|
cd4 positive alpha beta t cell proliferation
|
GO:0035739 |
2 |
0.029
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.029
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.029
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.029
|
|
|
|
regulation of immunoglobulin production in mucosal tissue
|
GO:2000557 |
1 |
0.029
|
|
|
|
cell cell junction maintenance
|
GO:0045217 |
3 |
0.029
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.028
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.028
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.028
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.028
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.028
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.028
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.028
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.028
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.027
|
|
|
|
regulation of type i hypersensitivity
|
GO:0001810 |
4 |
0.027
|
|
|
|
positive regulation of camp dependent protein kinase activity
|
GO:2000481 |
3 |
0.027
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.027
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.027
|
|
|
|
organ or tissue specific immune response
|
GO:0002251 |
13 |
0.027
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.027
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.027
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.027
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.027
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.027
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.027
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.027
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.026
|
|
|
|
leukotriene metabolic process
|
GO:0006691 |
7 |
0.026
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.026
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.026
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.026
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.026
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.026
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.026
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.026
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.026
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.026
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.026
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.026
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.025
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.025
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.025
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.025
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.025
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.025
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.025
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.025
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.025
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.025
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.024
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.024
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.024
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.024
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.024
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.024
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class i
|
GO:0042590 |
6 |
0.024
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.024
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.024
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.024
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.024
|
|
|
|
inflammatory cell apoptotic process
|
GO:0006925 |
11 |
0.024
|
|
|
|
negative regulation of type i hypersensitivity
|
GO:0001811 |
1 |
0.024
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.023
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.023
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.023
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.023
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.023
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.023
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.023
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.023
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.022
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.022
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.022
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.022
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.022
|
|
|
|
macrophage migration inhibitory factor signaling pathway
|
GO:0035691 |
2 |
0.022
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.022
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.022
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.022
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.022
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.022
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.022
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.022
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.022
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.022
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.022
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.021
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.021
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.021
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.021
|
|
|
|
positive regulation of antimicrobial peptide production
|
GO:0002225 |
1 |
0.021
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.021
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.021
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.021
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.021
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.021
|
|
|
|
regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000583 |
2 |
0.021
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.021
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.021
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.021
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.021
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.021
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.021
|
|
|
|
antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii
|
GO:0002504 |
17 |
0.021
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.021
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.021
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.021
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.021
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.021
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.021
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.021
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.020
|
|
|
|
regulation of epithelial cell differentiation involved in kidney development
|
GO:2000696 |
10 |
0.020
|
|
|
|
positive regulation of dendritic cell dendrite assembly
|
GO:2000549 |
1 |
0.020
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.020
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.020
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.020
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.020
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.020
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.020
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.020
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.020
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.020
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
|
positive regulation of type iia hypersensitivity
|
GO:0001798 |
4 |
0.019
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.019
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.019
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.019
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.019
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.019
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.019
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.019
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.019
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.019
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
42 |
0.019
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.019
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.019
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.019
|
Mouse |
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.019
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.019
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.019
|
|
|
|
positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0045425 |
2 |
0.019
|
|
|
|
acute inflammatory response to antigenic stimulus
|
GO:0002438 |
12 |
0.018
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.018
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.018
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
25 |
0.018
|
|
|
|
granulocyte macrophage colony stimulating factor production
|
GO:0032604 |
3 |
0.018
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.018
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.018
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.018
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.018
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.018
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.018
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.018
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.018
|
|
|
|
negative regulation of fibroblast proliferation
|
GO:0048147 |
14 |
0.018
|
|
|
|
regulation of hypersensitivity
|
GO:0002883 |
10 |
0.018
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.018
|
|
|
|
positive regulation of cytokine production involved in immune response
|
GO:0002720 |
19 |
0.018
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.018
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.018
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.018
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.018
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.018
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.017
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.017
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.017
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.017
|
|
|
|
negative regulation of fatty acid transport
|
GO:2000192 |
1 |
0.017
|
|
|
|
renal protein absorption
|
GO:0097017 |
1 |
0.017
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.017
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.017
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.017
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.017
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.017
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.017
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.017
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.017
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.017
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.017
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.017
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.017
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.017
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.017
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.017
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.017
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.017
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.017
|
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
39 |
0.017
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.017
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.017
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.016
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.016
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.016
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.016
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.016
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.016
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.016
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.016
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.016
|
|
